Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pandoraon Jun 13, 2022 10:45pm
126 Views
Post# 34754023

RE:RE:RE:Linda's deal sheet - detailed numbers are not the norm

RE:RE:RE:Linda's deal sheet - detailed numbers are not the norm
Engcan77 wrote: I would say "well done" in hiring Linda, and giving Sirona a chance in signing a deal with a top 10 pharma company. Which, as we found out today, she pulled through on her task. Brilliant!!
We do not know the terms of the deal, however i would assume she got the best deal that was available to Sirona. This is just my opinion. Her experience gets me to this point. Unless someone else panicked again, and gave up the farm just to complete the deal. (Nothing indicates this,at this time)

We have all heard "sell on news"...looks like this could be the case here. Plus, the uncertainty again because for the second time, there is no numbers connected to the news release. 
Sirona is in a better place today because of Linda.  Plus, i would assume her work will continue to make more deals. Hopefully they will come thick and fast, now a top 10 is connected to Sirona.
Although my disappointment is huge today after the market reaction to the news release, i feel very positive in the direction we are going in. Thank you Linda




Yes, you've got it. You used the word "hopefully" which I have read many times is not the way to decide in investing in any particular company. It now also falls into that other category of "potential".
It has a ton more potential this week than it had last week. I have had numerous companies over the years that were touted to be high in potential but I was very unsuccessful in carrying any of that 'potential' to the bank and depositing it. "Hopefully" this "potential" will be different.
<< Previous
Bullboard Posts
Next >>